Study: Bone Medications May Reduce Colon Cancer Risk

by: cancercompass

Bone drugs known as bisphosphonates, which are used for the treatment of osteoporosis, have been associated with a reduced risk of breast cancer. And according to a new study published in the Journal of Clinical Onocology, the use of oral bisphosphonates was also associated with a 59% reduction in the risk of colon cancer development.

"These [new] findings are meaningful because they point to a possible protective effect of this class of drugs being relevant to prevention of many different cancers," lead researcher Dr. Gad Rennert, from the Technion-Israel Institute of Technology Faculty of Medicine, told HealthDay.

Rennert and his team of researchers studied 933 postmenopausal female patients and controls. The use of bisphosphonates for more than one year was associated with a reduced risk.

"The lower risk of colorectal cancer risk seen among bisphosphonate users in this study is intriguing," Eric Jacobs of the American Cancer Society, told Reuters. "However, these results should be interpreted with caution and require confirmation by additional studies."

To learn more about the cancers featured in this post, please visit our breast cancer information and colon cancer information pages.